Navigation Links
Genes May Influence Reactions to Painkillers
Date:6/20/2012

WEDNESDAY, June 20 (HealthDay News) -- Genetics play a major role in a person's risk for addiction or unpleasant side effects when taking opioid painkillers, new research suggests.

Opioids, also called narcotics, are commonly prescribed to treat moderate to severe pain and include drugs such as morphine, methadone and oxycodone.

Some people experience debilitating side effects when taking opioids, while others have no problems. Similarly, some people can take these medications for months with little chance of addiction, while others are at risk within weeks.

To examine these patient differences, researchers from the Stanford University School of Medicine assessed the responses of more than 120 twin pairs and non-related people who were given the opioid alfentanil, a short-acting painkiller prescribed by anesthesiologists.

One finding of the study was that identical twins were more similar in their responses to the drug than non-identical twins, which suggests that genetics are a major factor.

Specifically, the researchers concluded that genetics play a significant role in a patients' variability for the risk of opioid side effects. They accounted for 59 percent of the variability for nausea, 38 percent of itchiness, 32 percent of dizziness and 30 percent of slowed breathing.

In addition, genetics accounted for 36 percent of drug disliking and 26 percent of drug liking, which are measures of addiction risk, according to the study published online June 20 in the journal Anesthesiology.

"The study is a significant step forward in efforts to understand the basis of individual variability in response to opioids, and to eventually personalize opioid treatment plans for patients," Dr. Martin Angst, one of the two principal investigators, said in a Stanford news release.

"Our findings strongly encourage the use of downstream molecular genetics to identify patients who are more likely or less likely to benefit from these drugs -- to help make decisions on how aggressive you want to be with treatment, how carefully you monitor patients and whether certain patients are suitable candidates for prolonged treatment," said Angst, a professor of anesthesia and director of the Stanford Human Pain Research Laboratory.

Earlier this year, the same team of researchers published a study that found that genetics account for 60 percent of the variability in the effectiveness of opioids in relieving pain.

More information

The U.S. Food and Drug Administration offers a guide to the safe use of pain medicines.

-- Robert Preidt

SOURCE: Stanford University, news release, June 20, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researchers ID Genes That May Determine Mental Illness
2. 2 repressor genes identified as essential for placental development
3. Genes Associated With Autism Also Related to Schizophrenia
4. Genes Might Cause Some to Shun Pork
5. Blond Genes May Vary Around the World
6. Mystery of the missing breast cancer genes
7. Living longer - variability in infection-fighting genes can be a boon for male survival
8. Genes Might Be Key to Parkinsons Spread
9. Strategy discovered to activate genes that suppress tumors and inhibit cancer
10. Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk
11. Obesity genes may influence food choices, eating patterns
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genes May Influence Reactions to Painkillers
(Date:12/8/2016)... ... 2016 , ... ZyDoc , a New York-based medical ... Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” has ... usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ natural ...
(Date:12/8/2016)... ... 08, 2016 , ... David J. Dykeman , Ginger Pigott , ... will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in ... the firm’s global Life Sciences & Medical Technology Group have been featured speakers at ...
(Date:12/8/2016)... ... 08, 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 ... the highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) ... Dr. Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) ...
(Date:12/8/2016)... California (PRWEB) , ... December 08, 2016 , ... ... has raised an $18M Series B led by Canvas Ventures . Other investors ... capital to scale its mobile platform to serve more consumers who are managing ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coppin Insurance Agency, an insurance and financial ... around the Cape Coral area, is embarking on a charity drive with the goal ... , The Harry Chapin Food Bank of Southwest Florida works to provide fresh and ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016  Hanson Research, an innovative leader in ... diffusion testing instruments for the pharmaceutical industry, announced ... Inc. ("Teledyne"). The move is designed to deepen ... instruments, as well as expand resources for further ... and services. Logo - http://photos.prnewswire.com/prnh/20161208/446988LOGO ...
(Date:12/8/2016)... FRANCISCO , Dec. 8, 2016 ... today announced that it has closed a $23 ... McKesson Ventures and OrbiMed. The company seeks to ... time physicians spend on mandated EHR documentation. The ... scribe service that frees doctors from 3 hours ...
(Date:12/8/2016)... LITTLE FALLS, N.J., Dec. 8, 2016 CANTEL MEDICAL ... net income of $18,800,000, or $0.45 per diluted share, on ... the first quarter ended October 31, 2016. This compares with ... sales of $153,779,000 for the first quarter ended October 31, ... the first quarter ended October 31, 2016 to $21,323,000, or ...
Breaking Medicine Technology: